Is This Biotech Stock After Groundbreaking Approval?
A breakthrough approval can move a biotech stock in dramatic ways. This guide breaks down how to assess the upside, m...
Learn the key factors to inspect when comparing funds, including costs, performance, and risk, to make informed investment choices.
18,912 articlesA breakthrough approval can move a biotech stock in dramatic ways. This guide breaks down how to assess the upside, m...
New Hampshire lawmakers pivot from a sweeping pro-housing mandate to targeted reforms after local pushback. HB1010 mo...
Legendary investor Paul Tudor Jones warns that the Trump-era market boom could end in a 30-35% correction, even as he...
Circle announces a $222 million Arc token presale at a $3 billion FDV, drawing major investors as quarterly revenue g...
A Washington nonprofit filed a federal lawsuit this week to stop the blue repainting of the Lincoln Memorial Reflecti...
U.S. Treasuries sell off as inflation and energy prices push yields toward 5%, signaling cautious sentiment in the de...
Inflation surprised to the upside in April, reviving debate over Fed policy and sending Bitcoin lower as higher yield...
A Medicare cost shock is hitting many retirees in 2026. This guide breaks down what happened, how it could affect you...
Ford stock rallies on stronger-than-expected results, lifting full-year guidance. ford zooms higher, easily outpacing...
Solana has risen about 4.5% over the past week as the Alpenglow upgrade advances in validator testing, stoking bets o...
Palantir just posted its first $1B-plus quarter, pushing it into the world’s top-25 by market value and redefining th...
A 56-year-old couple with $2.7 million saved must rethink withdrawal plans for a 35- to 40-year retirement, adopting ...